BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17382264)

  • 1. Biochemistry of neuroendocrine tumours.
    de Herder WW
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):33-41. PubMed ID: 17382264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours.
    Tomassetti P; Migliori M; Lalli S; Campana D; Tomassetti V; Corinaldesi R
    Ann Oncol; 2001; 12 Suppl 2():S95-9. PubMed ID: 11762360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers for gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
    Kanakis G; Kaltsas G
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):791-802. PubMed ID: 23582919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].
    Kianmanesh R; O'toole D; Sauvanet A; Ruszniewski P; Belghiti J
    J Chir (Paris); 2005; 142(3):132-49. PubMed ID: 16142076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours.
    Stridsberg M; Eriksson B; Lundqvist G; Skogseid B; Wilander E; Oberg K
    Regul Pept; 1995 Jan; 55(2):119-31. PubMed ID: 7754100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes.
    Hofland J; Falconi M; Christ E; Castaño JP; Faggiano A; Lamarca A; Perren A; Petrucci S; Prasad V; Ruszniewski P; Thirlwell C; Vullierme MP; Welin S; Bartsch DK
    J Neuroendocrinol; 2023 Aug; 35(8):e13318. PubMed ID: 37578384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multimodal imaging of pancreatic neuroendocrine tumors].
    Müssig K; Bares R; Dudziak K; Horger M
    Rofo; 2008 May; 180(5):373-9. PubMed ID: 18464198
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.
    Seregni E; Ferrari L; Bajetta E; Martinetti A; Bombardieri E
    Ann Oncol; 2001; 12 Suppl 2():S69-72. PubMed ID: 11762355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pancreatic neuroendocrine tumors].
    Burgos L; Burgos ME
    Rev Med Chil; 2004 May; 132(5):627-34. PubMed ID: 15279151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor markers in neuroendocrine tumors.
    Eriksson B; Oberg K; Stridsberg M
    Digestion; 2000; 62 Suppl 1():33-8. PubMed ID: 10940685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour markers in neuroendocrine tumours.
    Oberg K; Janson ET; Eriksson B
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S160-2. PubMed ID: 10604122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroendocrine tumors of the pancreas].
    Gorgone A; Calbo L; Melita G; Riso F; Tigano D; Barbuscia M
    Chir Ital; 1999; 51(4):309-12. PubMed ID: 10633841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic neuroendocrine tumors.
    Batcher E; Madaj P; Gianoukakis AG
    Endocr Res; 2011; 36(1):35-43. PubMed ID: 21226566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostics and treatment in functional pancreatic neuroendocrine tumours].
    Müssig K; Dudziak K; Horger M; Anlauf M; Goretzki PE
    Dtsch Med Wochenschr; 2011 Jun; 136(24):1319-30. PubMed ID: 21656454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of non-Zollinger-Ellison syndrome, non-carcinoid syndrome, enteropancreatic neuroendocrine tumours.
    Metz DC
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S153-9. PubMed ID: 10604121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of calcium provocative test in the diagnosis of gastroenteropancreatic endocrine tumors.
    Vezzadini C; Poggioli R; Casoni I; Vezzadini P
    Panminerva Med; 1996 Dec; 38(4):255-8. PubMed ID: 9063035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine tumors: common presentations of uncommon diseases.
    Kirkwood KS; Debas HT
    Compr Ther; 1995 Dec; 21(12):719-25. PubMed ID: 8789136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment strategy for enteropancreatic neuroendocrine tumor].
    Doi R; Tsukada T
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():71-8. PubMed ID: 16457224
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuroendocrine tumors of the gastrointestinal tract].
    Arnold C
    Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.